AzTrials
AzTrials

Emergence AgitationNCT06218680

Efficacy of Low Dose Propofol Given at the End of Sevoflurane Anesthesia for Prevention of Emergence Agitation in Pediatric Patient Undergoing MRI Scan

A study testing Propofol and Normal saline in people with Emergence Agitation, run by Khon Kaen University at 1 site in Thailand.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The goal of this clinical trial is to compare Efficacy of low dose propofol(0.5 mg/kg) vs placebo given at the end of sevoflurane anesthesia for prevention of emergence agitation in pediatric patient undergoing MRI scan. Read more about this study

Who is it for?
Ages 1 year to 8 years
Conditions the study is for
Emergence Agitation
What is being tested?
Propofol and Normal saline
Type of treatment
Injection or infusion
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
134 participants
Where
1 siteThailand
Study dates
20 Jan 2024to 30 Apr 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 year to 8 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Age 2-8 years
  • ASA class I or II ,who schedule for MRI scan under sevoflurane anesthesia

Who cannot join

  • Developmental delay
  • Psychological and neurological disorders
  • Abnormal airway
  • Reactive airway disease
  • Allergy to propofol, egg product
  • Family history of malignant hyperthermia
  • Need iv sedative medication before induction
  • Obesity

Trial locations and contacts

1 site in 1 country.

Santhita Pimonbut, M.D. contact

66943624641

Santhita.p@kkumail.com

Thailand1 site
  • Khon kaen University

    Khon Kaen, Muang, 40002

    Santhita Pimonbut, M.D., santhita.p@kkumail.com

    Chakthip Suttinarakorn, M.D.

Other trials in Thailand

About this study

The goal of this clinical trial is to compare Efficacy of low dose propofol(0.5 mg/kg) vs placebo given at the end of sevoflurane anesthesia for prevention of emergence agitation in pediatric patient undergoing MRI scan. The main question it aims to answer is "Can low dose propofol reduce the incidence of emergence agitation after general anesthesia?" Participants will be given propofol 0.5 mg/kg or saline according to the allocated group at the completion of MRI scan

Being tested
Propofol, Normal saline
Medical subject headings
Emergence Delirium

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PropofolDrug

    recieve propofol 0.5 mg/kg intravenously at end of sevoflurane anesthesia

  • Normal salineDrug

    recieve propofol 0.5 mg/kg intravenously at end of sevoflurane anesthesia

Study groups in NCT06218680
Study groupRoleWhat they receive
group PExperimentalReceive 0.5 mg/kg of propofol intravenously at end of sevoflurane anesthesia
Receives: Drug: Propofol
group SPlacebo comparatorReceive saline intravenously at end of sevoflurane anesthesia
Receives: Drug: Normal saline

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. incidence of emergence agitation

    Measured: at 5,10,15,20,25,30 minutes after extubation

Secondary outcomes (4)
  1. Incidence of complication

    Nausea or vomiting, airway obstruction, laryngospasm, desaturation and apnea

    Measured: 2 hours after extubation

  2. Use of rescue medication

    use of ondansetron, atropine

    Measured: 2 hours after extubation

  3. Emergence time

    duration of emergence

    Measured: 2 hours after extubation

  4. Length of stay in post anesthetic care unit

    Measured: 2 hours after extubation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jan 2024
  2. Study start20 Jan 2024 (estimated)
  3. Primary completion30 Apr 2025 (estimated)
  4. Study completion30 Apr 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
RCT
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
134 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06218680
Sponsor's protocol ID
HE661348
Status last verified
Jan 2024
First submitted
12 Jan 2024
Last updated
23 Jan 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: all collected individual participant data

Publications

  • Kulka PJ, Bressem M, Tryba M. Clonidine prevents sevoflurane-induced agitation in children. Anesth Analg. 2001 Aug;93(2):335-8, 2nd contents page.

    PubMed 11473855
  • Welborn LG, Hannallah RS, Norden JM, Ruttimann UE, Callan CM. Comparison of emergence and recovery characteristics of sevoflurane, desflurane, and halothane in pediatric ambulatory patients. Anesth Analg. 1996 Nov;83(5):917-20. doi: 10.1097/00000539-199611000-00005.

    PubMed 8895263
  • Aouad MT, Yazbeck-Karam VG, Nasr VG, El-Khatib MF, Kanazi GE, Bleik JH. A single dose of propofol at the end of surgery for the prevention of emergence agitation in children undergoing strabismus surgery during sevoflurane anesthesia. Anesthesiology. 2007 Nov;107(5):733-8. doi: 10.1097/01.anes.0000287009.46896.a7.

    PubMed 18073548
  • Cravero JP, Beach M, Thyr B, Whalen K. The effect of small dose fentanyl on the emergence characteristics of pediatric patients after sevoflurane anesthesia without surgery. Anesth Analg. 2003 Aug;97(2):364-367. doi: 10.1213/01.ANE.0000070227.78670.43.

    PubMed 12873918
  • Costi D, Ellwood J, Wallace A, Ahmed S, Waring L, Cyna A. Transition to propofol after sevoflurane anesthesia to prevent emergence agitation: a randomized controlled trial. Paediatr Anaesth. 2015 May;25(5):517-23. doi: 10.1111/pan.12617. Epub 2015 Jan 13.

    PubMed 25586124
  • Ramlan AAW, Pardede DKB, Marsaban AHMS, Hidayat J, Peddyandhari FS. Efficacy of 0.5 mg/kg of propofol at the end of anesthesia to reduce the incidence of emergence agitation in children undergoing general anesthesia with sevoflurane. J Anaesthesiol Clin Pharmacol. 2020 Apr-Jun;36(2):177-181. doi: 10.4103/joacp.JOACP_257_19. Epub 2020 Jun 15.

    PubMed 33013031
  • Abu-Shahwan I. Effect of propofol on emergence behavior in children after sevoflurane general anesthesia. Paediatr Anaesth. 2008 Jan;18(1):55-9. doi: 10.1111/j.1460-9592.2007.02376.x.

    PubMed 18095967
  • Ruenhunsa T, Pimonbut S, Sangsungnern P, Wittayapairoch P, Sripadungkul D, Wongsaneha N, Sorit W, Narrutto P. Effect of Low-Dose Propofol Administered at the End of Sevoflurane Anesthesia on Emergence Agitation in Pediatric Patients Undergoing MRI: A Randomized Controlled Trial. Anesthesiol Res Pract. 2026 Sep 1;2026:6532790. doi: 10.1155/anrp/6532790. eCollection 2026.

    PubMed 42688410

Questions about this trial

What is this clinical trial studying?

A study testing Propofol and Normal saline in people with Emergence Agitation, run by Khon Kaen University at 1 site in Thailand.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 23 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Thailand. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Santhita Pimonbut, M.D. (66943624641, Santhita.p@kkumail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

incidence of emergence agitation (time frame: at 5,10,15,20,25,30 minutes after extubation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06218680, which also lists 8 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jan 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in